Early life Bifidobacterium bifidum BD-1 intervention alleviates hyperactivity of juvenile female rats with attention deficit hyperactivity disorder.
10.12122/j.issn.1673-4254.2025.04.04
- Author:
Yang YANG
1
;
Kai WANG
1
;
Jianxiu LIU
1
;
Zhimo ZHOU
1
;
Wen JIA
1
;
Simou WU
1
;
Jinxing LI
1
;
Fang HE
1
;
Ruyue CHENG
1
Author Information
1. West China School of Public Health/ West China Fourth Hospital, Sichuan University, Chengdu 610041, China.
- Publication Type:Journal Article
- Keywords:
Bifidobacterium bifidum BD-1;
attention deficit hyperactivity disorder;
early life;
microbiota-gut-brain axis;
neuroinflammation
- MeSH:
Animals;
Female;
Rats;
Rats, Inbred WKY;
Rats, Inbred SHR;
Attention Deficit Disorder with Hyperactivity/therapy*;
Bifidobacterium bifidum;
Probiotics/therapeutic use*;
Dopamine Plasma Membrane Transport Proteins/metabolism*;
Tyrosine 3-Monooxygenase/metabolism*;
Gastrointestinal Microbiome;
Disease Models, Animal
- From:
Journal of Southern Medical University
2025;45(4):702-710
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the effects of early life intervention with Bifidobacterium bifidum BD-1 (B. bifidum BD-1) on hyperactivity in a female mouse model of attention deficit hyperactivity disorder (ADHD) and explore the underlying mechanisms.
METHODS:Eight newborn female Wistar-Kyoto (WKY) rats and 6 spontaneous hypertensive rats (SHRs) were gavaged with saline and another 6 SHRs were gavaged with B. bifidum BD-1 (109 CFU) daily for 3 weeks. Open field test of the rats was conducted at 7 weeks, and fecal samples were collected at weaning (3 weeks) and at 7 weeks for 16S rRNA sequencing. Immunofluorescent staining was used to detect dopamine transporter (DAT) and tyrosine hydroxylase (Th) levels in the striatum and activated microglia in the prefrontal cortex. Treg cells in the mesenteric lymph nodes, spleen and blood were analyzed using flow cytometry.
RESULTS:The SHRs traveled a significantly greater distance in open fields test than WKY rats, and this behavior was significantly attenuated by B. bifidum BD-1 intervention. The expression of DAT and Th in the striatum was significantly lower in the SHRs than in WKY rats, while B. bifidum BD-1 treatment obviously increased Th levels in the SHRs. B. bifidum BD-1 intervention significantly deceased the number of activated microglia and increased Treg cell counts in the spleen of SHRs. The treatment also enhanced α diversity in gut microbiota of the SHRs and resulted in a decreased Firmicutes/Bacteroidota ratio, more active Muribaculaceae growth, and suppression of Clostridia_UCG-014 proliferation.
CONCLUSIONS:Early life intervention with B. bifidum BD-1 alleviates hyperactivity in female SHRs by modulating the gut microbiota and peripheral immune response, suppressing neuroinflammation and improving dopaminergic system function. These findings provide evidence for early prevention strategies and support the development and application of psychobiotics for ADHD.
